All In Biotech

Drug Trial Radar · NCT06524544

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

A Phase III Randomized Trial of Pembrolizumab in Combination With Sacituzumab Govitecan-hziy vs Standard of Care in Anti-PD(L)1-Resistant Advanced Urothelial Cancer

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 320 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

320

Planned (sponsor's estimate)

Start

Dec 2, 2025

Primary completion

Dec 31, 2030

Study completion Dec 31, 2030

Sponsor

Sponsor type
NIH
First posted
Jul 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial compares the effectiveness of pembrolizumab and sacituzumab govitecan-hziy to standard of care in treating patients with urothelial cancer that has spread to nearby tissue or lymph nodes (locally advanced) or that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Sacituzumab govitecan-hziy is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug called govitecan-hziy. Sacituzumab attaches to TROP2 positive tumor cells in a targeted way and delivers govitecan-hziy to kill them. The usual treatment approach is treatment with chemotherapy such as cisplatin, carboplatin, gemcitabine, docetaxel or paclitaxel. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making deoxyribonucleic acid and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Paclitaxel is in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Giving pembrolizumab and sacituzumab govitecan-hziy may be more effective than usual care of carboplatin or cisplatin with gemcitabine, docetaxel or paclitaxel in treating patients with locally advanced or metastatic urothelial cancer.

Conditions

  • Locally Advanced Urothelial Carcinoma
  • Metastatic Urothelial Carcinoma
  • Unresectable Urothelial Carcinoma

Interventions

  • Biospecimen CollectionProcedure

    Undergo blood sample collection

  • CarboplatinDrug

    Given IV

  • CisplatinDrug

    Given IV

  • Computed TomographyProcedure

    Undergo CT

  • DocetaxelDrug

    Given IV

  • GemcitabineDrug

    Given IV

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • PaclitaxelDrug

    Given IV

  • PembrolizumabBiological

    Given IV

  • Questionnaire AdministrationOther

    Ancillary studies

  • Sacituzumab GovitecanBiological

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival (OS)Time frame: From randomization to death due to any cause, assessed up to 5 years

Locations

163 sites in 1 country. Site status is shown where the registry gives one.

  • Cancer Center at Saint Joseph's

    Phoenix, Arizona · Recruiting

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Recruiting

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California · Recruiting

  • UF Health Cancer Institute - Gainesville

    Gainesville, Florida · Recruiting

  • Emory University Hospital Midtown

    Atlanta, Georgia · Recruiting

  • Emory University Hospital/Winship Cancer Institute

    Atlanta, Georgia · Recruiting

  • Emory Saint Joseph's Hospital

    Atlanta, Georgia · Recruiting

  • Kootenai Health - Coeur d'Alene

    Coeur d'Alene, Idaho · Recruiting

  • Kootenai Clinic Cancer Services - Post Falls

    Post Falls, Idaho · Recruiting

  • Kootenai Clinic Cancer Services - Sandpoint

    Sandpoint, Idaho · Recruiting

  • University of Illinois

    Chicago, Illinois · Recruiting

  • Carle at The Riverfront

    Danville, Illinois · Recruiting

  • Cancer Care Specialists of Illinois - Decatur

    Decatur, Illinois · Recruiting

  • Decatur Memorial Hospital

    Decatur, Illinois · Recruiting

  • Carle Physician Group-Effingham

    Effingham, Illinois · Recruiting

  • Crossroads Cancer Center

    Effingham, Illinois · Recruiting

  • Carle Physician Group-Mattoon/Charleston

    Mattoon, Illinois · Recruiting

  • Carle BroMenn Medical Center

    Normal, Illinois · Recruiting

  • Carle Cancer Institute Normal

    Normal, Illinois · Recruiting

  • Cancer Care Center of O'Fallon

    O'Fallon, Illinois · Recruiting

  • HSHS Saint Elizabeth's Hospital

    O'Fallon, Illinois · Recruiting

  • Memorial Hospital East

    Shiloh, Illinois · Recruiting

  • Southern Illinois University School of Medicine

    Springfield, Illinois · Recruiting

  • Springfield Clinic

    Springfield, Illinois · Recruiting

  • Springfield Memorial Hospital

    Springfield, Illinois · Recruiting

  • Carle Cancer Center

    Urbana, Illinois · Recruiting

  • Mary Greeley Medical Center

    Ames, Iowa · Recruiting

  • McFarland Clinic - Ames

    Ames, Iowa · Recruiting

  • McFarland Clinic - Boone

    Boone, Iowa · Suspended

  • Mercy Hospital

    Cedar Rapids, Iowa · Recruiting

  • Oncology Associates at Mercy Medical Center

    Cedar Rapids, Iowa · Recruiting

  • McFarland Clinic - Trinity Cancer Center

    Fort Dodge, Iowa · Recruiting

  • McFarland Clinic - Jefferson

    Jefferson, Iowa · Suspended

  • McFarland Clinic - Marshalltown

    Marshalltown, Iowa · Recruiting

  • HaysMed

    Hays, Kansas · Recruiting

  • University of Kansas Cancer Center

    Kansas City, Kansas · Recruiting

  • Lawrence Memorial Hospital

    Lawrence, Kansas · Recruiting

  • The University of Kansas Cancer Center - Olathe

    Olathe, Kansas · Recruiting

  • University of Kansas Cancer Center-Overland Park

    Overland Park, Kansas · Recruiting

  • Salina Regional Health Center

    Salina, Kansas · Recruiting

Showing 40 of 163 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.